Mammoth Biosciences researchers have developed NanoCas, an ultracompact CRISPR nuclease, demonstrating its ability to perform gene editing in non-liver tissues, including skeletal muscle, using a ...

Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction ...

Previous studies in mice have shown that gene editing may be used to potentially treat conditions such as anxiety. While CRISPR/Cas9 represents a revolutionary gene editing technology, its delivery to ...

Rahman Oladigbolu, a 52-year-old Harvard-educated film maker with sickle cell disease, poses for a photo. Born in Nigeria, he is very interested in Casgevy, the CRISPR-based sickle cell treatment that ...

In a study published May 1 in Proceedings of the National Academy of Sciences, a research team led by scientists from the Lewis Katz School of Medicine at Temple University and the University of ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The lone volunteer in a gene-editing study ...

Scientists have designed a slimmed-down CRISPR protein, enEbCas12a, that still packs a punch in precision editing. Its small size means it can hitch a ride in a harmless virus, delivering edits ...